Skip to main content
. 2014 Mar 28;17(1):61–68. doi: 10.4048/jbc.2014.17.1.61

Table 3.

Meta anlaysis of side effects of sorafenib combined with chemotherapy for treatment of HER2-negative advanced breast cancer

graphic file with name jbc-17-61-i003.jpg

HER2=human epidermal growth factor receptor 2; CI=confidence interval; HFSR/HFS=hand-foot skin reaction/hand-foot syndrome.